These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6583794)

  • 1. [Development of secondary neoplasms in Hodgkin's disease as sequelae of oncologic therapy].
    Hartmann D
    Schweiz Rundsch Med Prax; 1984 Jan; 73(4):95-8. PubMed ID: 6583794
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary malignant tumors following treatment of Hodgkin's disease].
    Shishkin IP
    Med Radiol (Mosk); 1984 Aug; 29(8):24-8. PubMed ID: 6590941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary malignancies following treatment of Hodgkin's disease].
    Wijlhuizen TJ; Breed WP
    Ned Tijdschr Geneeskd; 1987 Aug; 131(31):1342-6. PubMed ID: 3477701
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute myeloid leukemia: a late complication of the treatment for Hodgkin's disease].
    Yahalom J; Polliack A
    Harefuah; 1983 May; 104(10):476-7. PubMed ID: 6578996
    [No Abstract]   [Full Text] [Related]  

  • 5. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P; Bonadonna G
    Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
    [No Abstract]   [Full Text] [Related]  

  • 6. [Letter: Secondary neoplasms complicating Hodgkin's disease].
    Focan C; Brictieux N; Lemaire M; Hugues J
    Nouv Presse Med; 1974 May; 3(21):1385. PubMed ID: 4527420
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
    Lipton JH; Gospodarowicz M; Reingold S
    Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary leukaemia in Hodgkin's disease.
    Selby P; Horwich A
    Lancet; 1986 May; 1(8488):1027-8. PubMed ID: 2871298
    [No Abstract]   [Full Text] [Related]  

  • 9. [Leukemic transformation in Hodgkin's disease].
    Krc I; Vojácek K
    Vnitr Lek; 1978 Sep; 24(9):910-4. PubMed ID: 279150
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hodgkin's disease evolving into acute leukemia. Report of 2 cases].
    Armenta D; Pretty HM; Long LA; Neemeh JA; Gosselin G
    Union Med Can; 1975 May; 104(5):744-8. PubMed ID: 1056113
    [No Abstract]   [Full Text] [Related]  

  • 11. Hodgkin's disease terminating in acute myeloid leukaemia.
    Mauri C; Quaglino D
    Haematologica; 1974 Mar; 59(1):86-90. PubMed ID: 4213144
    [No Abstract]   [Full Text] [Related]  

  • 12. Secondary malignancies in a child with Hodgkin's disease: T-cell lymphoma and myelodysplastic syndrome evolving into acute nonlymphoblastic leukaemia.
    Polychronopoulou S; Panagiotou JP; Papadakis T; Mavrou A; Anagnostou D; Haidas S
    Med Pediatr Oncol; 1996 May; 26(5):359-66. PubMed ID: 8614370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute myeloid leukemia in the course of Hodgkin's disease].
    Kuse R; Hausmann K
    Dtsch Med Wochenschr; 1977 Dec; 102(49):1824. PubMed ID: 271072
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary acute myeloid leukemia early after therapy for Hodgkin's disease--a case report.
    Mihailov G; Ganeva P; Vassileva N; Guenova M; Balacenko G; Toshkov S; Hodjadjik D
    J BUON; 2007; 12(3):403-6. PubMed ID: 17918297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
    Sobecks RM; Le Beau MM; Anastasi J; Williams SF
    Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications for combined treatment in Hodgkin's disease. Review of the literature].
    González San Segundo C; Santos Miranda JA
    Rev Clin Esp; 1997 Nov; 197(11):783-9. PubMed ID: 9547201
    [No Abstract]   [Full Text] [Related]  

  • 18. [Primary non-Hodgkin's lymphoma of the esophagus following Hodgkin's disease].
    Fernández-Llamazares J; de la Cruz J; Bianchi A; Ribera JM
    Med Clin (Barc); 1999 Mar; 112(9):356-7. PubMed ID: 10220770
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenesis in Hodgkin's disease.
    Colman M
    Hematol Oncol; 1984; 2(1):2-4. PubMed ID: 6588020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.